Essential medicines and health products

News and events

2018

WHO prequalifies breakthrough vaccine for typhoid

03 JANUARY 2018 - At the end of December 2017, WHO prequalified the first conjugate vaccine for typhoid, Bharat Biotech’s Typbar-TCV®. Typhoid conjugate vaccines (TCVs) are innovative products that have longer-lasting immunity than older vaccines, require fewer doses, and can be given to young children through routine childhood immunization programs.

2017

WHO prequalifies over 17 vector control products, paving way for increased control of malaria and other major vector-borne diseases

18 December 2017 - In the fastest ever prequalification process, WHO has assessed and listed 17 products for use in controlling vector borne diseases, including long lasting insecticidal bed nets, indoor residual sprays, space sprays, larvicides and insecticide-treated net kits.

WHO recommends the most stringent level of international control for synthetic opioid carfentanil

13 December 2017 - WHO has this week endorsed a recommendation from the Expert Committee on Drug Dependence (ECDD) to include carfentanil, an analogue of the prescription opioid fentanyl, into Schedules I and IV of the 1961 UN Single Convention on Narcotic Drugs. Schedule I substances are subject to strict drug control measures.

Events

  • 10 - 12 October 2017

    Global Vaccine Safety

    10th Vaccine Safety Initiative Strategic Priority Group Retreat and 6th Global Vaccine Safety Initiative Meeting
    Kuala Lumpur, Malaysia

  • 27 November - 01 December 2017

    Substandard and Falsified (SF) Medical Products

    Sixth meeting of the Member State mechanism on SSFFC medical products
    WHO, Geneva